🇺🇸 FDA
Pipeline program

ORMD-0801 capsules- 2x8mg

HSC20140476H

Phase 2 small_molecule completed

Quick answer

ORMD-0801 capsules- 2x8mg for Type 1 Diabetes is a Phase 2 program (small_molecule) at ORAMED PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ORAMED PHARMACEUTICALS INC.
Indication
Type 1 Diabetes
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials